Tom Ramseier, Ph.D.
About Tom Ramseier, Ph.D.
Tom Ramseier, Ph.D., serves as the Vice President of Synthetic Biology, Bioengineering, and Bioprocess at LifeMine Therapeutics, where he has worked since 2020. He has a strong background in molecular and systems biology, having held leadership roles at various biotechnology companies and established significant capabilities in microbial development and genetic engineering.
Work at LifeMine Therapeutics
Tom Ramseier, Ph.D. serves as the Vice President of Synthetic Biology, Bioengineering & Bioprocess at LifeMine Therapeutics. He has held this position since 2020, contributing to the company's focus on innovative approaches in drug discovery and development. His role involves overseeing the integration of synthetic biology and bioengineering techniques to enhance bioprocesses. His leadership aims to streamline the development of natural product-based therapeutics.
Previous Experience in Biotechnology
Prior to his current role, Tom Ramseier founded Ramseier Biotech Consulting in 2020, where he provided strategic insights for biotechnology projects for ten months. He also held significant positions at Dow Chemical Company, where he worked as an R&D Leader in Molecular and Systems Biology from 2000 to 2006. His tenure at Metabolix, Inc. as Director of Microbial Development from 2006 to 2014 further solidified his expertise in microbial development and product innovation.
Education and Expertise
Tom Ramseier earned his Ph.D. in Natural Sciences from ETH Zürich, a prestigious institution known for its rigorous scientific programs. His educational background provides a strong foundation for his work in synthetic biology and bioengineering. He has developed expertise in genetic engineering tools, including CRISPR-Cas9, and has a deep understanding of microbial strain engineering.
Achievements in Safety and Innovation
Throughout his career, Tom Ramseier has strongly advocated for safety in laboratory and production environments, achieving a zero-incident safety record. He has established Molecular Forensics capabilities to combat counterfeit and illegal products. His efforts led to the successful delivery of microbial strains with improved productivity for commercial manufacturing and obtaining EPA approval for the commercial production of natural products.
Career at Dow AgroSciences
From 2014 to 2019, Tom Ramseier worked at Dow AgroSciences as the Microbial Strain Engineering Leader. In this role, he implemented advanced genetic engineering tools and techniques to enhance microbial strains. His contributions significantly advanced the company's capabilities in developing high-yield natural products for agricultural applications.